Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53

Citation
Jn. Li et al., Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53, CANCER RES, 61(4), 2001, pp. 1493-1499
Citations number
44
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
61
Issue
4
Year of publication
2001
Pages
1493 - 1499
Database
ISI
SICI code
0008-5472(20010215)61:4<1493:PIOFAS>2.0.ZU;2-4
Abstract
Patty acid synthetic metabolism is abnormally elevated in tumor cells, and pharmacological inhibitors of the anabolic enzyme fatty acid synthase (FAS) , including the natural product cerulenin and the novel synthetic compound c75, are selective inhibitors of tumor cell growth. We have recently report ed that these two FAS inhibitors both produce rapid, potent inhibition of D NA replication and S-phase progression in human cancer cells, as well as ap optotic death, Here we report an additional characterization of the cellula r response to FAS inhibition. RKO colon carcinoma cells were selected for s tudy because they undergo little apoptosis within the first 24 h after FAS inhibition. Instead, RKO cells exhibited a biphasic stress response with a transient accumulation in S and G(2) at 4 and 8 h that corresponds to a mar ked reduction in cyclin A- and B1-associated kinase activities, and then by accumulation of p53 and p21 proteins at 16 and 24 h and growth arrest in G (1) and G(2). The response of RKO cells to FAS inhibition resembled a genot oxic stress response, but DNA damage did not appear to be an important down stream effect of FAS inhibition, because none was detected using the single cell gel electrophoresis assay (comet assay) to assess DNA damage. p53 fun ction is probably important in protecting RKO cells from FAS inhibition bec ause, similar to many other tumor lines, RKO cells expressing a dominant ne gative mutant p53 gene underwent extensive apoptosis within 24 h after FAS inhibition. Sensitization of cells to FAS inhibitors by the loss of p53 rai ses the possibility that these agents may be clinically useful against mali gnancies carrying p53 mutations, Whereas induction of apoptosis appeared re lated to accumulation of the substrate, malonyl-CoA, after FAS inhibition, the cytostatic effects mere independent of malonyl-CoA accumulation and may have resulted from product depletion.